A Study of Tolerability and Efficacy of Cannabidiol on Motor Symptoms in Parkinson's Disease | MicrobiomeTrials← Back to trialsNCT03582137
A Study of Tolerability and Efficacy of Cannabidiol on Motor Symptoms in Parkinson's Disease
CompletedPHASE2INTERVENTIONAL
Trial Details
Start: 2018-09-05Est. Completion: 2022-01-04
Enrollment target: 74 participants Locations- University of Colorado hospital, Aurora, Colorado, United States
Other microbiome trials you might be interested in
Alzheimer Disease
This study will primarily investigate the safety and secondarily the effect and applicability of Transcranial Pulse Wave…
Potsdam, GermanyEst. completion Oct 1, 2026
Patients With SynucleinopathiesNeurogenic Orthostatic HypotensionPure Autonomic FailureREM Sleep Behavior DisorderParkinson DiseaseDementia With Lewy BodiesMultiple System AtrophyShy-Drager Disease
Synucleinopathies are a group of rare diseases associated with worsening neurological deficits and the abnormal accumula…
Boston, United States
Est. completion Dec 30, 2026
Parkinson Disease
Sleep-wake disturbances are common in Parkinson's disease. These disturbances are associated with a decline in patients'…
Grenoble, FranceEst. completion Jul 2028